Reports

Ideas That Generate Results

List of Figures:

Figure 4-1: India - Personal Disposable Income (Trillion US$), 2012-2016
Figure 4-2: India - Population 60 years or above (Million), 2015 & 2030
Figure 4-3: India - Number of Births (Million), 2015-2022
Figure 4-4: India - Population (Billion), 2015 & 2030
Figure 5-1: India - Influenza Vaccine Market (Million US$), 2015 & 2020
Figure 5-2: India - Influenza Vaccine Market (Million Doses), 2015 & 2020
Figure 5-3: India - Influenza Vaccine Market by Key Products (%), 2015
Figure 5-4: Share of Influenza Market in Potential Market (%), 2015
Figure 5-5: Share of Influenza Market in Potential Market (%), 2020
Figure 6-1: India - Influenza Vaccine Distribution to Government Organizations
Figure 6-2: India - Influenza Vaccine Distribution to Private Organizations
Figure 6-3: India - Influenza Vaccine Cold Chain System
Figure 7-1: India - Influenza Vaccine Market by Key Players (%), 2015
Figure 8-1: Cipla Limited - Breakup of Revenue by Geography (%), 2015
Figure 8-2: Lupin Limited - Revenues by Trade (Billion US$), 2016
Figure 8-3: Lupin Limited - Commercialized Influenza Vaccine
Figure 8-4: Abbott Laboratories - Net Sales by Business Segment (%), 2015
Figure 8-5: Abbott Laboratories - Net Sales by Geography (%), 2015
Figure 8-6: GlaxoSmithKline Plc - Breakup of Total Revenues by Business Segment (%), 2015
Figure 8-7: GlaxoSmithKline Plc - Breakup of Vaccine Segment by Type (%), 2015
Figure 8-8: GlaxoSmithKline Plc - Breakup of Total Revenues by Geography (%), 2015
Figure 8-9: Sanofi - Breakup of Total Revenues by Business Segment (%), 2015
Figure 8-10: Sanofi Pasteur - Breakup of Vaccine Segment by Type (%), 2015
Figure 8-11: Sanofi Pasteur - Breakup of Total Influenza Vaccine Revenues by Geography (%), 2015
Figure 8-12: CSL Ltd - Breakup of Total Revenues by Major Products (%), 2016
Figure 8-13: CSL Ltd - Breakup of Total Revenues by Region (%), 2016

List of Tables:

Table 5-1: India - Import Data of Vaxigrip (Million Doses), 2014-2016
Table 5-2: India - Import Data of Influvac (Million Doses), 2014-2016
Table 5-3: India - Import Data of Agrippal & Fluarix (Million Doses), 2014-2016
Table 5-4: Potential Patients for Influenza (2015 & 2020)
Table 6-1: India - Major Influenza Vaccines Price/Unit (US$)
Table 6-2: India - Major Influenza Vaccines Import Price/Unit (US$)
Table 6-3: India - Number of Government Cold Chain Stores
Table 8-1: Cipla Limited - Financials (Million US$), FY2014-FY2016
Table 8-2: Cipla Limited - Commercialized Influenza Vaccine
Table 8-3: Bharat Biotech - Commercialized Influenza Vaccine
Table 8-4: Panacea Biotec Limited - Financials (Million US$), FY2014-FY2016
Table 8-5: Panacea Biotec Limited - Commercialized Influenza Vaccine
Table 8-6: Zydus Cadila - Financials (Million US$), FY2014-FY2016
Table 8-7: Zydus Cadila - Commercialized Influenza Vaccine
Table 8-8: Lupin Limited - Revenues by Business Segment (Billion US$), 2016
Table 8-9: Abbott Laboratories - Financials (Billion US$), 2013-2015
Table 8-10: Abbott India Limited. – Commercialized Influenza Vaccine
Table 8-11: GlaxoSmithKline Plc - Key Financials (Million US$), 2013-2015
Table 8-12: GlaxoSmithKline Plc - Commercialized Influenza Vaccine
Table 8-13: Sanofi - Key Financials (Million US$), 2013-2015
Table 8-14: Sanofi Pasteur - Commercialized Influenza Vaccine
Table 8-15: CPL Biologicals Pvt. Ltd. - Commercialized Influenza Vaccine
Table 8-16: Serum Institute of India Pvt. Ltd. - Commercialized Influenza Vaccine
Table 8-17: CSL Ltd. - Key Financials (Million US$), 2014-2016
Table 8-18: Seqirus - Commercialized Influenza Vaccine